Home

Sorrento Therapeutics, Inc.

CIK 850261 · last filed 2023-10-05

Sorrento Therapeutics, Inc. is a corporate insider who has filed 8 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for CELUW, was dated Oct 5, 2023. Current disclosed insider exposure totals $210.9K across reported positions. The firm reports its address in San Diego, CA. 62 SEC filings were submitted jointly with Henry Ji.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$210.9K

Companies

2

Total Filings

8

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
4955 DIRECTORS PLACE
SAN DIEGO, CA 92121
Phone
(858) 203-4100
State of Incorporation
DE
Formerly Known As
QUIKBYTE SOFTWARE INC (2006–2009)
Related Filers
Henry Ji — 62 joint filings, latest 2023-03-20
Kim Janda — 24 joint filings, latest 2023-02-06
OPKO HEALTH, INC. — 20 joint filings, latest 2019-05-09
JAISIM SHAH — 17 joint filings, latest 2021-08-30
PATRICK SOON-SHIONG — 14 joint filings, latest 2016-07-11
Ally Bridge Group Capital Partners II, L.P. — 13 joint filings, latest 2020-02-14
Scilex Holding Co — 13 joint filings, latest 2023-09-26
ERNST-GUENTER AFTING — 11 joint filings, latest 2013-10-31
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Celularity Inc (CELUW) Delisted 10%+ Owner 5,050,427 $0.00 $9.6K $0 1 2023-10-05
SCLXW 10%+ Owner 1,917,210 $0.11 $210.9K $0 7 2023-09-25

Recent Filings

8 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-10-05 Celularity Inc (CELUW) Delisted Sell (S) −15,371,697 $0 EDGAR
2023-09-25 SCLXW Sell (S) −60,068,585 $0 EDGAR
2023-01-23 SCLXW Other (J) −73,740,795 $0 EDGAR
2022-12-02 SCLXW Buy (P) — $0 EDGAR
2022-11-25 SCLXW Buy (P) — $0 EDGAR
2022-11-23 SCLXW Buy (P) — $0 EDGAR
2022-11-22 SCLXW Buy (P) — $0 EDGAR
2022-11-15 SCLXW Other (J) — $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.